Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration

被引:43
作者
Berent-Spillson, Alison
Russell, James W.
机构
[1] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[2] Univ Michigan, Neurosci Program, Ann Arbor, MI USA
[3] Vet Affairs Med Ctr, Baltimore, MD USA
关键词
diabetic neuropathy; glutathione; metabotropic glutamate receptor; oxidative stress; Schwann cell;
D O I
10.1111/j.1471-4159.2006.04373.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High glucose concentrations cause oxidative injury and programmed cell death in neurons, and can lead to diabetic neuropathy. Activating the type 3 metabotropic glutamate receptor (mGluR3) prevents glucose-induced oxidative injury in dorsal root ganglion neurons co-cultured with Schwann cells. To determine the mechanisms of protection, studies were performed in rat dorsal root ganglion neuron-Schwann cell co-cultures. The mGluR3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate prevented glucose-induced inner mitochondrial membrane depolarization, reactive oxygen species accumulation, and programmed cell death, and increased glutathione (GSH) concentration in co-cultured neurons and Schwann cells, but not in neurons cultured without Schwann cells. Protection was diminished in neurons treated with the GSH synthesis inhibitor L-buthionine-sulfoximine, suggesting that mGluR-mediated protection requires GSH synthesis. GSH precursors and the GSH precursor GSH-ethyl ester also protected neurons from glucose-induced injury, indicating that GSH synthesis in Schwann cells, and transport of reaction precursors to neurons, may underlie mGluR-mediated neuroprotection. These results support the conclusions that activating glial mGluR3 protects neurons from glucose-induced oxidative injury by increasing free radical scavenging and stabilizing mitochondrial function, through increased GSH antioxidant defense.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 72 条
[11]   Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells [J].
Delaney, CL ;
Russell, JW ;
Cheng, HL ;
Feldman, EL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (02) :147-160
[12]   Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress [J].
Deng, WB ;
Wang, H ;
Rosenberg, PA ;
Volpe, JJ ;
Jensen, FE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7751-7756
[13]   Glutathione metabolism in brain - Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species [J].
Dringen, R ;
Gutterer, JM ;
Hirrlinger, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (16) :4912-4916
[14]   Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursor for neuronal glutathione [J].
Dringen, R ;
Pfeiffer, B ;
Hamprecht, B .
JOURNAL OF NEUROSCIENCE, 1999, 19 (02) :562-569
[15]   THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY [J].
DYCK, PJ ;
KRATZ, KM ;
KARNES, JL ;
LITCHY, WJ ;
KLEIN, R ;
PACH, JM ;
WILSON, DM ;
OBRIEN, PC ;
MELTON, LJ .
NEUROLOGY, 1993, 43 (04) :817-824
[16]   THE USE OF MONOCHLOROBIMANE TO DETERMINE HEPATIC GSH LEVELS AND SYNTHESIS [J].
FERNANDEZCHECA, JC ;
KAPLOWITZ, N .
ANALYTICAL BIOCHEMISTRY, 1990, 190 (02) :212-219
[17]  
Fujimura M, 1999, J NEUROSCI, V19, P3414
[18]   Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity [J].
Gegg, ME ;
Clark, JB ;
Heales, SJR .
BRAIN RESEARCH, 2005, 1036 (1-2) :1-6
[19]   Thiol-disulfide balance: From the concept of oxidative stress to that of redox regulation [J].
Ghezzi, P ;
Bonetto, V ;
Fratelli, M .
ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (7-8) :964-972
[20]   Altered redox status in patients with diabetes mellitus type I [J].
Gil-Del Valle, L ;
Milian, LD ;
Toledo, A ;
Vilaró, N ;
Tápanes, R ;
Otero, MA .
PHARMACOLOGICAL RESEARCH, 2005, 51 (04) :375-380